Biden Praises Pharma to Donors as He Pushes to Cut Prices
Biden Praises Pharma to Donors as He Pushes to Cut Prices
Bloomberg
Joe Biden
2020 Presidential election
drug pricing
Flag link:
Biogen taps machine learning to help answer doctors' drug questions
Biogen taps machine learning to help answer doctors' drug questions
Fierce Pharma
Biogen
Lexalytics
machine learning
artificial intelligence
physicians
Flag link:
Pfizer and Catalia’s robot wellness coach aims to help patients take their meds
Pfizer and Catalia’s robot wellness coach aims to help patients take their meds
Pharmaforum
Pfizer
Catalia Health
artificial intelligence
patients
patient adherence
Flag link:
Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say
Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say
Stat
China
trade secrets
Flag link:
Alder won’t solve Lundbeck’s headaches
Alder won’t solve Lundbeck’s headaches
EP Vantage
Lundbeck
M&A
Alder Biopharmaceuticals
migraines
Flag link:
Prostate drug may slow Parkinson’s progression, big data suggests
Prostate drug may slow Parkinson’s progression, big data suggests
Fierce Biotech
terazosin
Parkinson's Disease
Flag link:
The Growing Prevalence of Clinically Integrated Networks
The Growing Prevalence of Clinically Integrated Networks
CP WIre
CINs
clinically integrated networks
Flag link:
September 16 2019 - Purdue Pharma files for bankruptcy
Flag link:
Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy
Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy
Stat
Purdue Pharma
oxycontin
bankruptcy
opioids
opioid crisis
Flag link:
AstraZeneca diabetes drug granted fast track status for heart failure treatment
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Flag link:
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Fierce Pharma
Amgen
Kyprolis
JNJ
Darzalex
Multiple Myeloma
Flag link:
Primary Care Is Integral To Improving U.S. Healthcare, But Is Falling Further Behind
Primary Care Is Integral To Improving U.S. Healthcare, But Is Falling Further Behind
Forbes
primary care
Flag link:
Lundbeck pens $2B Alder takeover to boost brain disease pipeline
Lundbeck pens $2B Alder takeover to boost brain disease pipeline
Fierce Biotech
Lundbeck
Alder Biopharmaceuticals
M&A
Flag link:
J&J taps AlivaMab for multi-target antibody discovery effort
J&J taps AlivaMab for multi-target antibody discovery effort
Fierce Biotech
JNJ
AlivaMab
antibody-drug conjugate
R&D
Flag link:
Novo Nordisk and Medtronic to integrate diabetes technology
Novo Nordisk and Medtronic to integrate diabetes technology
Pharmaforum
Novo Nordisk
Medtronic
diabetes
devices
blood glucose monitoring
Flag link:
Celgene's AML drug clears late-stage test
Celgene's AML drug clears late-stage test
Endpoints
Celgene
AML
CC-486
acute myeloid leukemia
Flag link:
Baxter to Acquire 1 of the 16 Most Promising Private Companies in Medtech
Baxter to Acquire 1 of the 16 Most Promising Private Companies in Medtech
Medical Devices and Diagnostics Industry
Baxter Healthcare
Cheetah Medical
M&A
devices
Flag link:
The Growing Prevalence of Clinically Integrated Networks
CINs
clinically integrated networks
Flag link:
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
Flag link:
ECTRIMS: Roche's Ocrevus, given early, cuts wheelchair risk by 42%
ECTRIMS: Roche's Ocrevus, given early, cuts wheelchair risk by 42%
Fierce Pharma
Roche
Ocrevus
multiple sclerosis
Flag link:

Pages